Sign in

The Clorox Company CLX

Price 94.3 USD
as of 2026-09-05
40/100
Weak
Quality60
Growth17
Balance-sheet strength32
Valuation36
Momentum30
Income75

Composite 40/100; the shares have moved about 36% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 17/100 — a strong mark against it.

Case for

Income ranks 75/100 — a strong point in its favour. Quality ranks 60/100 — a slight point in its favour.

Case against

Growth ranks 17/100 — a strong mark against it. Momentum ranks 30/100 — a moderate mark against it. Balance-sheet strength ranks 32/100 — a moderate mark against it.

What the company does The Clorox Company manufactures and markets consumer and professional cleaning, household, lifestyle, and international products under brands such as Clorox, Glad, Kingsford, Brita, and Burt’s Bees.

Key financials Key metrics include ROE 164%, ROA 8%, ROCE 18%, gross margin 42%, operating margin 13%, net margin 9%, revenue growth -5%, EPS growth -26%, debt/equity 22%, and dividend yield 5%.

Stock health SideraVIA scores show average quality (61), weak growth (18), below-average strength (32), poor valuation (33), weak momentum (27), and strong income (74). Piotroski F-Score is 4/9 and Altman Z is 2.20.

Price vs fair value The stock trades at a discount of 4.10% versus the analyst mean target of 101.65. - Net margin contracted to 9% from prior levels (key financials). - Revenue declined -5% and EPS fell -26% (key financials). - SideraVIA valuation percentile is 33/100 (SideraVIA). - Momentum is negative over 6m -21% and 12m -13% (momentum). - Dividend payout is 90%, above the 80% threshold (key financials).

Looking forward Forward P/E of 18.45 and PEG of 0.86 suggest improved earnings visibility if growth stabilizes, while current margins and momentum remain headwinds.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.